Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

FDA Drug Recalls

18,003 recalls, newest first

Class I · High risk

GoHARD 25000

Marketed without an approved NDA/ANDA: Products found to contain undeclared sildenafil and/or tadalafil.

Ongoing Chemical / undeclared Pyramids Wholesale Inc. D-0453-2024
Class I · High risk

Pink Pussycat Honey

Marketed without an approved NDA/ANDA: Products found to contain undeclared sildenafil and/or tadalafil.

Ongoing Chemical / undeclared Pyramids Wholesale Inc. D-0452-2024
Class I · High risk

Samurai-X Honey 6800

Marketed without an approved NDA/ANDA: Products found to contain undeclared sildenafil and/or tadalafil.

Ongoing Chemical / undeclared Pyramids Wholesale Inc. D-0451-2024
Class I · High risk

Flower Power

Marketed without an approved NDA/ANDA: Products found to contain undeclared sildenafil and/or tadalafil.

Ongoing Chemical / undeclared Pyramids Wholesale Inc. D-0450-2024
Class I · High risk

Weiner Boner Honey

Marketed without an approved NDA/ANDA: Products found to contain undeclared sildenafil and/or tadalafil.

Ongoing Chemical / undeclared Pyramids Wholesale Inc. D-0449-2024
Class I · High risk

Spanish Fly 22K capsules

Marketed without an approved NDA/ANDA: Products found to contain undeclared sildenafil and/or tadalafil.

Ongoing Chemical / undeclared Pyramids Wholesale Inc. D-0448-2024
Class II · Moderate risk

Tri-Lo-Sprintec

Failed Dissolution Specifications

Terminated Dissolution failure Teva Pharmaceuticals USA, Inc NDC 0093-2140-62 D-0428-2024
Class III · Low risk

Digoxin Tablets

Cross Contamination with Other Products:(mycophenolate mofetil).

Terminated Cross-contamination Novitium Pharma LLC NDC 70954-201-20 D-0389-2024
Class II · Moderate risk

Febuxostat Tablets 80mg

CGMP Deviations: Microbial contamination was reported in stagnant water in the duct of the manufacturing equipment.

Ongoing Microbial contamination Sun Pharmaceutical Industries INC NDC 16714-060-01 D-0369-2024
Class II · Moderate risk

Febuxostat Tablets 40mg

CGMP Deviations: Microbial contamination was reported in stagnant water in the duct of the manufacturing equipment.

Ongoing Microbial contamination Sun Pharmaceutical Industries INC NDC 16714-059-01 D-0368-2024
Class II · Moderate risk

S.P Labs

Failed Stability Specifications

Completed Stability / shelf life Specialty Process Labs LLC D-0447-2024
Class II · Moderate risk

S.P.Labs

Failed Stability Specifications

Completed Stability / shelf life Specialty Process Labs LLC NDC 81305-500-01 D-0446-2024
Class II · Moderate risk

FentaNYL citrate

Lack of Assurance of Sterility: Firm did not perform process validation.

Ongoing Sterility / contamination SSM Health Care St. Louis DBA SSM St. Clare Health Center D-0436-2024
Class II · Moderate risk

Phenylephrine HCl

Lack of Assurance of Sterility: Firm did not perform process validation.

Ongoing Sterility / contamination SSM Health Care St. Louis DBA SSM St. Clare Health Center D-0435-2024

Recalls by year